Genenta Science SPA
NASDAQ:GNTA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Genenta Science SPA
Other Current Liabilities
Genenta Science SPA
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Genenta Science SPA
NASDAQ:GNTA
|
Other Current Liabilities
€426k
|
CAGR 3-Years
92%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Philogen SpA
MIL:PHIL
|
Other Current Liabilities
€1.9m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Ulisse Biomed Spa
MIL:UBM
|
Other Current Liabilities
€120.7k
|
CAGR 3-Years
-44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genenta Science SPA's Other Current Liabilities?
Other Current Liabilities
426k
EUR
Based on the financial report for Dec 31, 2023, Genenta Science SPA's Other Current Liabilities amounts to 426k EUR.
What is Genenta Science SPA's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 3Y
92%
Over the last year, the Other Current Liabilities growth was -5%. The average annual Other Current Liabilities growth rates for Genenta Science SPA have been 92% over the past three years .